一个智能的mRNA启动的治疗学多shRNA纳米工厂,用于精确和高效的癌症基因治疗
Ming Shi1, Yifang He2, Xiaohong Zhong2
1Department of Chemistry and Pharmacy, Guilin Normal College, Guilin, 541004, China.
Advanced healthcare materials
|January 10, 2025
概括
研究人员开发了一种新型纳米工厂 (RNF@CM),用于精确的癌症治疗. 该系统可以扩大癌细胞中短毛针RNA (shRNA) 的产生,提高基因疗法的效率,并使瘤在体内诊断和治疗具有最小的毒性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 分子生物学分子生物学
背景情况:
- 短毛针RNA (shRNA) 介导的基因疗法显示出希望,但由于选择性和效率低,在癌症治疗方面面临挑战.
- 开发有针对性的输送系统对于有效的体内基因疗法至关重要.
研究的目的:
- 设计和评估一个mRNA启动的自主多shRNA纳米工厂 (RNF@CM),用于增强体内癌症成像和治疗.
- 提高shRNA传递精确癌症治疗的选择性和效率.
主要方法:
- 采用金纳米粒子核心,DNA/RNA混合探针,aptamer抑制的DNA聚合酶和癌细胞膜构建的RNF@CM.
- 利用细胞内瘤相关的mRNA启动循环链位移聚合反应,用于shRNA放大和光释放.
- 评估了RNF@CM区分癌细胞,产生shRNA,在体内诊断瘤和抑制瘤生长的能力.
主要成果:
- 通过mRNA目标,RNF@CM证明了癌细胞的特定传递和启动.
- 仅在癌细胞中实现了放大光和连续产生多个shRNA.
- 在体内成功诊断出瘤,并显著抑制瘤生长,毒性微不足道.
结论:
- RNF@CM系统为按需基因传递和精确的癌症治疗术提供了一种新的方法.
- 这种纳米工厂提高了shRNA疗法的选择性和效率,克服了临床应用中的关键局限性.
- RNF@CM扩展了针对癌症治疗和诊断成像的工具包.
相关概念视频
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K


